Actualités 908 Devices Inc - MASS | Actions NASDAQ | ADVFN

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
908 Devices Inc (MASS)
908 Devices Inc (MASS) Actualités

908 Devices Inc (MASS)

2,26

0,24

(11,88%)

Fermé 12 Janvier 10:00PM

Retardé de 15 minutes

2,34

0,08

(3,54%)

Après les heures de négociation: 1:41AM

Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Current Report Filing (8-k)

0001555279 false 0001555279 2022-11-14 2022-11-14 iso4217:USD xbrli:shares...

908 Devices Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Outlook

Q3 2022 revenue increases 26% over prior year, with gross margin of 59% 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and...

908 Devices Records Strong Momentum in Life Sciences Sector

Driven by Biopharma 4.0, proteomics research and acquisition of TRACE Analytics, 908 Devices empowers more effective drug discoveries 908...

908 Devices Launches Pesticide Identification Capability to Thwart Illegal Marijuana Growing Operations

Developed in coordination with the U.S. Forest Service, the MX908 can identify toxic pesticides that pose...

908 Devices to Participate in Upcoming Investor Conferences

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

908 Devices to Report Third Quarter 2022 Financial Results on November 14, 2022

908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today...

908 Devices and CPI Improve mAbs Cell Culture Outcomes Using At-line Media Analysis

REBEL mass spec device used to reduce toxic metabolite accumulation while increasing cell viability and titer by up to 40% 908 Devices (Nasdaq:...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

Current Report Filing (8-k)

0001555279 false 0001555279 2022-08-09 2022-08-09 iso4217:USD xbrli:shares...

908 Devices Reports Second Quarter 2022 Financial Results and Reiterates 2022 Revenue Outlook

Q2 2022 revenue increases 34% over prior year, with gross margin of 60% 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and...

7
8
9
Suivant

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales